Intellectual Property Portfolio
Granted patents in the US, Japan and Russia
PCTS Filed Covering 5 Areas Of Innovation
1
Administration
- Intranasal ExoPTEN (granted in the US and pending in other countries)
This covers and protects our Exo-PTEN technology, drug composition, and methods for non-invasive intranasal administration of exosome-based treatment.
2
Exosomes and Large Scale Production
- 2 PCTs on Production and Composition of Matter of our exosomes
- 2D and 3D production to achieve exosome potency
3
API
- Provisional patents describing siRNA sequences to inhibit PTEN production (ExoPTEN)
4
Loading Technology
- Incubation allows efficient loading
- No genetic engineering
- Loading doesn’t interact with cell membrane biochemistry, uses natural pathway that maintains integrity of exosomes
- Non-toxic, natural conjugate media
- Loading occurs post-production
